Phosphatidylethanolamine-mediated metabolic membrane remodeling in obesity-associated Alzheimer's disease: mechanisms, neuroimmune crosstalk, and therapeutic potential.

Ahmad M, Aijaz M, Ansari MA, Afzal M

Open source

DOI
10.1007/s11011-026-01960-3
Published
2026 Sep 1
Container
Metabolic brain disease
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11011-026-01960-3,
  title = {Phosphatidylethanolamine-mediated metabolic membrane remodeling in obesity-associated Alzheimer's disease: mechanisms, neuroimmune crosstalk, and therapeutic potential.},
  author = {Ahmad M and Aijaz M and Ansari MA and Afzal M},
  year = {2026},
  journal = {Metabolic brain disease},
  doi = {10.1007/s11011-026-01960-3},
  url = {https://doi.org/10.1007/s11011-026-01960-3}
}

RIS

TY  - JOUR
TI  - Phosphatidylethanolamine-mediated metabolic membrane remodeling in obesity-associated Alzheimer's disease: mechanisms, neuroimmune crosstalk, and therapeutic potential.
AU  - Ahmad M
AU  - Aijaz M
AU  - Ansari MA
AU  - Afzal M
PY  - 2026
JO  - Metabolic brain disease
DO  - 10.1007/s11011-026-01960-3
UR  - https://doi.org/10.1007/s11011-026-01960-3
ER  - 

APA

M, A., M, A., MA, A., & M, A. (2026). Phosphatidylethanolamine-mediated metabolic membrane remodeling in obesity-associated Alzheimer's disease: mechanisms, neuroimmune crosstalk, and therapeutic potential.. Metabolic brain disease. https://doi.org/10.1007/s11011-026-01960-3

Source records